Immune Predictors of Response after Bacillus Calmette-Guérin Treatment in Non-Muscle-Invasive Bladder Cancer.
Authors: Rodríguez-Izquierdo M,  et al
Journal: Cancers (Basel). 2023 Nov
DOI: 10.3390/cancers15235554

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.
Authors: Rio, P.,  et al
Journal: Mol Ther Nucleic Acids. 2023 Oct
DOI: 10.1016/j.omtn.2023.102066.

Advances and Challenges in the Development of Gene Therapy Medicinal Products for Rare Diseases.
Authors: Bueren JA,  et al
Journal: Hum Gene Ther. 2023 Sep
DOI: 10.1089/hum.2023.152

MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction. 
Authors: Yáñez R et al
Journal: Frontiers in Immunology 2023 Jul;
DOI: 10.3389/fimmu.2023.1193179

Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides
Authors: Fañanas-Baquero, S. et al
Journal: Front. Genome Ed. 2023 Apr;
DOI: 10.3389/fgeed.2023.1104666

Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
Authors: Lasaga, M.. et al
Journal: Haematologica. 2023 Apr;
DOI: 10.3324/haematol.2022.282418

Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
Authors: Errazquin, R. et al
Journal: Cancers 2023 Mar;
DOI: 10.3390/cancers15061871

Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer. 
Authors: Juan, A. et al
Journal:  Cancer Nano 2023 Mar;
DOI: 10.1186/s12645-023-00180-z

Clustered regularly interspaced short palindromic repeats/Cas9-mediated gene editing. A promising strategy in hematological disorders
Authors: Ugalde, L. et al
Journal: Cytotherapy. 2023 Mar;
DOI: 10.1016/j.jcyt.2022.11.014

Access to gene therapy for rare diseases when commercialization is not fit for purpose.
Authors: Fox T et al
Journal: Nat Med. 2023 Feb ;
DOI: 10.1038/s41591-023-02208-8

Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model
Authors: Hervás-Salcedo, R. et al
Journal: Frontiers in Immunology 2023 Feb;
DOI: 10.3389/fimmu.2023.1062086

Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.
Authors: Siegner SM et al
Journal: Nat Commun. 2022
DOI: 10.1038/s41467-022-34479-z

Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Authors: Errazquin R. et al
Journal: Oral Oncol. 2022 Nov
DOI: 10.1016/j.oraloncology.2022.106184.

Enforced mesenchymal stem cell tissue colonization counteracts immunopathology
Authors: García-Bernal D. et al
Journal: NPJ Regen Med. 2022 Oct
DOI: 10.1038/s41536-022-00258-z.

Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transferinduced arthritis
Authors: Lopez-Santalla, M. et al
Journal: Front Immunol. 2022 Oct
DOI: 10.3389/fimmu.2022.943293

Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
Authors: Mesa-Núñez C. et al
Journal: Methods & Clinical Development 2022 Sep
DOI: 10.1016/j.omtm.2022.07.015

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.
Authors: Suarez-Cabrera C. et al
Journal: Eur Urol. 2022 Sep 
DOI: 10.1016/j.eururo.2022.08.011

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors.
Authors: García M. et al
Journal: Mol Ther Methods Clin Dev. 2022 Sep  
DOI: 10.1016/j.omtm.2022.09.005.

Antitumor applications of polyphenol-conjugated turnip mosaic virus-derived nanoparticles.
Authors: Velázquez-Lam E. et al
Journal: Nanomedicine (Lond). 2022 Aug
DOI: 10.2217/nnm-2022-0067

Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis.
Authors: Chacón-Solano E  et al
Journal: Matrix Biol. 2022 Aug
DOI: 10.1016/j.matbio.2022.06.007

Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
Authors: Casado, J. A. et al
Journal: J Clin Invest. 2022 Aug
DOI: 10.1172/JCI142842

Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.
Authors: Rodrigo JP. A. et al
Journal: Oral Dis. 2022 Aug
DOI: 10.1111/odi.14350

Ambra1 haploinsufficiency in CD1 mice results in metabolic alterations and exacerbates age-associated retinal degeneration.
Authors: Ramírez-Pardo I. et al
Journal: Autophagy. 2022 Jul
DOI: 10.1080/15548627.2022.2103307

Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma. 
Authors: Lázaro S. et al
Journal: Cancers (Basel). 2022 Jul
DOI: 10.3390/cancers14153671.

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes.
Authors: Sanchez-Baltasar R. et al
Journal: The CRISPR Journal. 2022 Jun
DOI: 10.1089/crispr.2022.0013

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer.
Authors: Duréndez-Sáez E, et al
Journal: Cancers (Basel). 2022 Jun
DOI: 10.3390/cancers14133216

G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Authors: Moreira-Silva F et al
Journal: Biomed Pharmacother. 2022 Jun
DOI: 110.1016/j.biopha.2022.113031

CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
Authors: Luque, J. et al
Journal: Clin Genet. 2022 May
DOI: 10.1111/cge.14113.

Gene Editing for Inherited Red Blood Cell Diseases
Authors: Quintana-Bustamante, O. et al
Journal: Frontiers in Physiology 2022 March
DOI: 10.3389/fphys.2022.848261

Translational research for bone marrow failure patients
Authors: Malouf,C. et al
Journal:  Exp Hematol. 2022 Jan
DOI: 10.1016/j.exphem.2021.11.004.

Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells
Authors: Albericio G. et al
Journal: Sci Rep. 2022 Jan
DOI: 10.1038/s41598-021-03956-8.

Generation of NKX2.5(GFP) Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts
Authors: Lopez-Muneta, L.  et al
Journal: Front Cell Dev Biol. 2022 Jan
DOI: 10.3389/fcell.2021.797927.

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
Authors: Lodewijk I.  et al
Journal: NPJ Precis Oncol. 2022 Jan
DOI: 10.1038/s41698-021-00247-3

IKKα Induces Epithelial-Mesenchymal Changes in Mouse Skin Carcinoma Cells That Can Be Partially Reversed by Apigenin
Authors: García-García VA.  et al
Journal: Int J Mol Sci. 2022 Jan
DOI: 10.3390/ijms23031375

Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer.
Authors: Bernardini A  et al
Journal: Cancers (Basel). 2022 Jan
DOI: 10.3390/cancers14020378.

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.
Authors: Rubio C  et al
Journal: Cancers (Basel). 2022 Jan
DOI: 10.3390/cancers14020287

 

 

ERAS, a Member of the Ras Superfamily, Acts as an Oncoprotein in the Mammary Gland
Autores: Suarez-Cabrera, C. et al
Revista y Año: Cancers 2021 Nov
DOI: 10.3390/cancers13215588

Autores: Lopez-Santalla M. et al
Revista y Año: Biomedicines. 2021 Oct
DOI: 10.3390/biomedicines9111507

Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment
Autores: Navarro, S. et al
Revista y Año: Mol Ther Methods Clin Dev. 2021 Jul
DOI: 10.1016/j.omtm.2021.07.006. 

Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
Autores: García-García, VA. et al
Revista y Año: Cells. 2021 Jul
DOI: 10.3390/cells10081906 

Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune Arthritis
Autores: Leceta, J. et al
Revista y Año: Front Immunol. 2021 Jul
DOI: 10.3389/fimmu.2021.701862

Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
Autores: Lopez-Santalla, M. , et al
Revista y Año: EBioMedicine. 2021 Jun
DOI:  10.1016/j.ebiom.2021.103427

Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
Autores: Bonafont, J. , et al
Revista y Año: Mol Ther. 2021 Jun 
DOI:  10.1016/j.ymthe.2021.02.019

Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis
Autores: Fernandez-Perez, Raquel. et al
Revista y Año: Front Immunol. 2021 Jun
DOI:  10.3389/fimmu.2021.687443

CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice
Autores: Josefa P. Alameda , et al
Revista y Año: Int. J. Mol. Sci. 2021 Jun
DOI:  10.3390/ijms22136736

Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency
Autores: Sara Fañanas-Baquero, et al
Revista y Año: Molecular Therapy - Methods & Clinical Development 2021 May
DOI: 10.1016/j.omtm.2021.05.001

Autores: Maria José Ramírez, et al
Revista y Año: Am J Hematol 2021 May
DOI: 10.1002/ajh.26234

A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease
Autores: Vega García-Escudero, et al
Revista y Año: Acta Neuropathol 2021 May
DOI: 10.1007/s00401-021-02317-z

Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis.
Autores: Baltanás FC, et al.
Revista y Año: Cancers (Basel). 2021 Apr 
DOI: 10.3390/cancers13092152

Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review
Autores: Vallina C, et al.
Revista y Año: Oral Oncol. 2021 Apr
DOI: 10.1016/j.oraloncology.2021.105310

Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
Autores: Errazquin, R, et al.
Revista y Año: Genes 2021 Apr
DOI: 10.3390/genes12040548

Cell Therapies in Bladder Cancer Management
Autores: Lucia Morales, et al.
Revista y Año: Int J Mol Sci. 2021 Mar 
DOI: 10.3390/ijms22062818.

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Autores: Iris Lodewijk, et al.
Revista y Año: Clin Epigenetics. 2021 Mar 
DOI: 10.1186/s13148-021-01046-0

Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes
Autores: Eva Gálvez, et al.
Revista y Año: Hemasphere, 2021 Mar 
DOI: 10.1097/HS9.0000000000000539

GSE4-loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
Autores: Pintado-Berninches L, et al.
Revista y Año: FASEB J. 2021 Mar
DOI: 10.1096/fj.202001160RR

The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
Autores: García-Bernal D, et al.
Revista y Año: Front. Cell Dev. Biol.,2021 Mar
DOI: 10.3389/fcell.2021.650664

Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10
Autores: Hervás-Salcedo R, et al.
Revista y Año: Stem Cell Res Ther. 2021 Feb
DOI: 10.1186/s13287-021-02193-0

Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
Autores: Carrascoso-Rubio C, et al.
Revista y Año: Stem Cell Res Ther. 2021 Jan
DOI: 10.1186/s13287-021-02145-8

 

 

Neuroendocrine Lung Cancer Mouse Models: An Overview 
Autores: Lorz C, et al.
Revista y Año: Cancers (Basel). 2020 Dec 
DOI: 10.3390/cancers13010014

Combined adipose mesenchymal stromal cell advanced therapy resolved a recalcitrant leg ulcer in an 85-year-old patient. 
Autores: Martínez-Santamaría L, et al.
Revista y Año: Regen Med. 2020 Nov 
DOI: 10.2217/rme-2020-0139

Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy
Autores: Alberto Vázquez, et al.
Revista y Año: Front Immunol. 2020 Nov
DOI: 10.3389/fimmu.2020.567391.

Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
Autores: Guccini I. et al.
Revista y Año: Cancer Cell 2020 Oct 
DOI: 10.1016/j.ccell.2020.10.012

In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells.
Autores: M Martinez-Lage et al.
Revista y Año: Nat Commun. 2020 Oct
DOI: 10.1038/s41467-020-18875-x

Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term
Autores: Lopez-Santalla, M. et al.
Revista y Año:  J of Crohn's and Colitis, 2020 Oct
DOI: 10.1093/ecco-jcc/jjaa079

In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9. 
Autores: Lopez-Manzaneda S, et al.
Revista y Año: Mol Ther Methods Clin Dev. 2020 Oct
DOI: 10.1016/j.omtm.2020.10.007

Overactivation of the NF-κB pathway impairs molar enamel formation. 
Autores: Yamada A, et al.
Revista y Año: Oral Dis. 2020 Oct
DOI: 10.1111/odi.13384

Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells
Autores: Rodriguez-Fornes, F. et al.
Revista y Año: Gene Ther. 2020 Sep
DOI: 10.1038/s41434-020-0144-x

Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies
Autores: Carvalho S. et al.
Revista y Año: Front Oncol. 2020 Sep
DOI: 10.3389/fonc.2020.01774

VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma
Autores: Lorenzo-Martín LF. et al.
Revista y Año: Nat Commun. 2020 Sep
DOI: 10.1038/s41467-020-18524-3

Theranostic Viral Nanoparticles for Autoimmune Diseases
Autores: Yuste-Calvo, C. et al.
Revista y Año: J Immuno Biol. 2020 Sep
DOI: 10.37421/JIB.2020.5.149

Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications
Autores: Lopez-Santalla, M. et al.
Revista y Año: Cells. 2020 Aug
DOI: 10.3390/cells9081852

DNA Methylation as a Therapeutic Target for Bladder Cancer
Autores: Nunes SP. et al.
Revista y Año: Cells 2020 Aug
DOI: 10.3390/cells9081850.0

G-protein-coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas
Autores: Palacios-García J, et al.
Revista y Año: Int J Cancer. 2020 Jul 
DOI: 10.1002/ijc.32838 

Pathogenic SREK1 decrease in Huntington's disease lowers TAF1 mimicking X-linked dystonia parkinsonism
Autores: Hernández IH. et al.
Revista y Año: Brain. 2020 Jul
DOI: 10.1093/brain/awaa150

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
Autores: Hermanova I. et al.
Revista y Año: J Exp Med. 2020 Jun
DOI: 10.1084/jem.20191787

Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation
Autores: Comella-Bolla, A.. et al.
Revista y Año: Mol Neurobiol. 2020 Jun
DOI: 10.1007/s12035-020-01907-4

Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer
Autores: Montanuy, Helena. et al.
Revista y Año: Clin Cancer Res 2020 Jun
DOI: 10.1158/1078-0432.ccr-19-1625

Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome.
Autores: Gálvez V,. et al.
Revista y Año: Mol Ther Methods Clin Dev. 2020 Jun
DOI: 10.1016/j.omtm.2020.05.031

Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.eling of Netherton Syndrome.
Autores: Nicoletti E. et al.
Revista y Año: Ann Hematol. 2020 May
DOI: 10.1007/s00277-020-03954-2

Natural estrogens enhance the engraftment of human hematopoietic stem and progenitor cells in immunodeficient mice
Autores: Fañanas-Baquero, S. et al.
Revista y Año: Haematol. 2020 Apr
DOI: 10.3324/haematol.2019.233924

The downregulated membrane expression of CD18 in CD34(+) cells defines a primitive population of human hematopoietic stem cells
Autores: Mesa-Nuñez, C. et al.
Revista y Año: Cell Res Ther. 2020 Apr
DOI: 10.1186/s13287-020-01672-0

TALEN mediated gene editing in a mouse model of Fanconi anemia
Autores: Pino-Barrio, M. J. et al.
Revista y Año: Sci Rep. 2020 Apr
DOI: 10.1038/s41598-020-63971-z

Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Autores: Brendel C. et al.
Revista y Año: Biochem Pharmacol. 2020 Apr
DOI: 10.1016/j.bcp.2019.113711.

Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
Autores: Israel López-Valero et al.
Revista y Año: Theranostics. 2020 Apr
DOI: 10.7150/thno.41450

Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
Autores: Bogliolo, M. et al.
Revista y Año: J Med Genet 2020 Apr
DOI: 10.1136/jmedgenet-2019-106249

Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.
Autores: Has C. et al.
Revista y Año: Br J Dermatol. 2020 Mar
DOI: 10.1111/bjd.18128

Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.
Autorers: Has C,. et al.
Revista y Año: Br J Dermatol. 2020 Mar
DOI: 10.3390/cells9081850.0

Humanization of Tumor Stroma by Tissue Engineering as a Tool to Improve Squamous Cell Carcinoma 
Autores: Guerrero-Aspizua S et al.
Revista y Año: Mol Sci. 2020 Mar 
DOI: 10.3390/ijms21061951

Helios modulates the maturation of a CA1 neuronal subpopulation required for spatial memory formation
Autores: Giralt, A. et al.
Revista y Año: Exp Neurol. 2020 Jan
DOI: 10.1016/j.expneurol.2019.113095

IKKbeta overexpression together with a lack of tumour suppressor genes causes ameloblastic odontomas in mice
Autores: Page, A. et al.
Revista y Año:  J Oral Sci. 2020 Jan
DOI: 10.1038/s41368-019-0067-9

IThe IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas
Autores: Gargini R,et al.
Revista y Año:  Science Translational Medicine 2020 Jan
DOI: 10.1126/scitranslmed.aax1501

A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors).
Autores: Mapelli SN,et al.
Revista y Año: Cancers (Basel). 2020 Jan
DOI: 10.3390/cancers12010176

Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
Autores: López-Mateo I,. et al.
Revista y Año: Thyroid. 2020 Jan
DOI: 10.1089/thy.2019.0175

Advances in the Gene Therapy of Monogenic Blood Cell Diseases
Autores: J. A. Bueren, et al.
Revista y Año: Clinical Genetics. 2020 Jan
DOI: 10.1111/cge.13593

Competitive Repopulation Assay of Long-Term Epidermal Stem Cell Regeneration Potential. 
Autores: Segrelles C  et al.
Revista y Año: Methods Mol Biol. 2020
DOI: 10.1007/7651_2019_234

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
Autores: Santos-de-Frutos K, et al.
Revista y Año: J Clin Med. 2019 Dec
DOI: 10.3390/jcm8122131

Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity.
Autores: Jiménez-Segovia A, et al.
Revista y Año: Neoplasia. 2019 Nov
DOI: 10.1016/j.neo.2019.10.001

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.
Autores: Castelo B. et al.
Revista y Año: Clin Transl Oncol. 2019 Nov
DOI: 10.1007/s12094-019-02073-3

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet. 
Autores: Martinez VG, et al.
Revista y Año: Front Genet. 2019 Nov
DOI: 10.3389/fgene.2019.01125

Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA
Autores: Quintana-Bustamante, O. et al.
Revista y Año: PLoS One. 2019 Oct 
DOI: 10.1371/journal.pone.0223775

Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.
Autores: Lázaro S et al.
Revista y Año: Proc Natl Acad Sci U S A. 2019 Oct 
DOI: 10.1073/pnas.1821745116

Elongated Flexuous Plant Virus-Derived Nanoparticles Functionalized for Autoantibody Detection
Autores: Yuste-Calvo, C. et al.
Revista y Año: Nanomaterials (Basel). 2019 Oct 
DOI: 10.3390/nano9101438

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses.
Autores: Chacón-Solano E et al.
Revista y Año: Br J Dermatol. 2019 Sep
DOI: 10.1111/bjd.17698

Deciphering the complexity of human non-coding promoter-proximal transcriptome.
Autores: Mapelli SN et al.
Revista y Año: Bioinformatics. 2019 Aug
DOI: 10.1093/bioinformatics/bty981

Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.
Autores: Guerrero-Aspizua S et al.
Revista y Año: Orphanet J Rare Dis. 2019 Jul
DOI: 10.1186/s13023-019-1158-6

Early, Non-Invasive Sensing of Sustained Hyperglycemia in Mice Using Millimeter-Wave Spectroscopy. 
Autores: Moreno-Oyervides A, et al.
Revista y Año: Sensors (Basel). 2019 Jul
DOI: 10.3390/s19153347

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Autores: Segovia, C, et al.
Revista y Año: Nature Medicine. 2019 Jul
DOI: 10.1038/s41591-019-0499

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.
Autores: Dueñas M,, et al.
Revista y Año: Sci Rep. 2019 Jul
DOI: 10.1038/s41598-019-46652-4

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.
Autores: Lwin SM, et al
Revista y Año: JCI Insight. 2019 Jun
DOI: 10.1172/jci.insight.126243

Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
Autores: Gunaratna RT.  et al.
Revista y Año: Oncogene. 2019 May
DOI: 10.1038/s41388-018-0630-4

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer. 
Autores: Loras A.  et al.
Revista y Año: Cancers (Basel). 2019 May
DOI: 10.3390/cancers11050686

Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.
Autores: Bonafont J.  et al.
Revista y Año: Mol Ther. 2019 May
DOI: 10.1016/j.ymthe.2019.03.007

Comprehensive Molecular Characterization of Squamous Cell Carcinomas
Autores: Corina Lorz. et al
Revista y Año: Hallmark and Treatment Modalities, Hamid Elia Daaboul, IntechOpen,
DOI: 10.5772/intechopen.85988

Frequent Alteration of Annexin A9 and A10 in HPV-Negative Head and Neck Squamous Cell Carcinomas: Correlation with the Histopathological Differentiation Grade. 
Autores: Salom C, et al.
Revista y Año: J Clin Med. 2019 Feb
DOI: 10.3390/jcm8020229

IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization. 
Autores: Page A. et al.
Revista y Año: Comput Struct Biotechnol J. 2019 Feb
DOI: 10.1016/j.csbj.2019.02.003

NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
Autores: Francisco Jose Román-Rodrıguez, et al.
Revista y Año: Cell Stem Cell. 2019 Nov
DOI: 10.1016/j.stem.2019.08.016

Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Autores: Río, Navarro et al.,
Revista y Año: Nature Medicine. 2019 Sep
DOI: 10.1038/s41591-019-0550-z

GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells
Autores: L. Pintado-Berninches, et al.
Revista y Año: Cell Death Differ,2019 Oct
DOI: 10.1038/s41418-018-0272-7

c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-beta-Induced Epithelial-Mesenchymal Transition and Regulates Cell Phenotypic Switch
Autores: L. Almale, et al.
Revista y Año: Stem Cells,2019 May 
DOI: 10.1002/stem.3038.

Premature aging and cancer development in transgenic mice lacking functional CYLD
Autores: J. P. Alameda, et al
Revista y Año: AGING. 2019 Jan
DOI: 10.18632/aging.101732

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency
Autores: P. Bianchi, et al.
Revista y Año: Am J Hematol. 2019 Jan
DOI: 10.1002/ajh.25325

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Autores: Rubio C, et al.
Revista y Año: Clin Cancer Res. 2019 Jan
DOI: 10.1158/1078-0432.CCR-18-0685